Inhibitor Therapeutics, Inc.
Pharmaceutical company · Tampa, Florida, United States · OTC: INTI
Inhibitor Therapeutics, Inc. is a pharmaceutical company headquartered in Tampa, Florida, United States. Its shares trade on OTC under the ticker INTI. It has reported private securities offerings to the US SEC, most recently $600,000 sold in a notice filed in 2016.
Inhibitor Therapeutics at a glance
What does Inhibitor Therapeutics do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $600,000 sold (2016).
Frequently asked questions about Inhibitor Therapeutics
Where is Inhibitor Therapeutics headquartered?
Inhibitor Therapeutics, Inc. is headquartered in Tampa, Florida, United States.
What does Inhibitor Therapeutics do?
Inhibitor Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Inhibitor Therapeutics a public company?
Yes. Inhibitor Therapeutics, Inc. trades on OTC under the ticker INTI.
Similar companies
- TuHURA Biosciences, Inc./NVTampa, Florida, United States
- Akari Therapeutics PlcTampa, Florida, United States
- Biovest International IncTampa, Florida, United States
- Intezyne Technologies, Inc.Tampa, Florida, United States
- Accentia Biopharmaceuticals IncTampa, Florida, United States
- Romark Laboratories, L.C.Tampa, Florida, United States
- Kurobe Pharmaceuticals, Inc.Tampa, Florida, United States
- AbbVie Inc.North Chicago, Illinois, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences